BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX

Rank in Stocks #27360
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Share Price
$0.04067041
Last synced: 2026-11-16
Market Cap
$14.99M
Change (1 day)
-0.39%
Change (1 year)
-28.04%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
Operating Margin for BCAL Diagnostics Limited (BDX)
Operating Margin as of November 2026 TTM: -5,145.88%
According to BCAL Diagnostics Limited's latest financial reports, its current operating margin (TTM) is -5,145.88%. At the end of 2025 the company had an operating margin of -46,043.03%.
Operating Margin history for BCAL Diagnostics Limited from 2018 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -5,145.88% -88.82%
2025 -46,043.03% 26,087.60%
2024 -175.82% 4.98%
2023 -167.48% -60.24%
2022 -421.26% -35.59%
2021 -654.03% 153.98%
2020 -257.51% -2.65%
2019 -264.52% -9.00%
2018 -290.68% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
17.98% -100.00%
US
20.38% -100.00%
US
43.02% -100.01%
CN
32.30% -100.01%
US
22.23% -100.00%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about BCAL Diagnostics Limited's operating margin

What is BCAL Diagnostics Limited's operating margin?

BCAL Diagnostics Limited's operating margin is -5,145.88%, as of Nov 2026.

What was BCAL Diagnostics Limited's operating margin in 2025?

In 2025, BCAL Diagnostics Limited's operating margin was -46,043.03%, compared with -175.82% in 2024.

How has BCAL Diagnostics Limited's operating margin changed since 2020?

From 2020 to 2025, BCAL Diagnostics Limited's operating margin was highest in 2023 (-167.48%) and lowest in 2025 (-46,043.03%).

How does BCAL Diagnostics Limited's operating margin compare with similar companies?

BCAL Diagnostics Limited's operating margin (-5,145.88%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.